EVALUATION OF THE THERAPEUTIC POTENTIAL OF BETA-2 AGONISTS IN THE TREATMENT OF MYOTONIC SYNDROMES AND HYPERKALEMICA PERIODIC PARALYSIS
- 2 Anni 1999/2001
- 55.777€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 1999 BRITISH JOURNAL OF PHARMACOLOGY
Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX
- 2001 BRAIN
Skeletal muscle disuse induces fibre type-dependent enhancement of Na+ channel expression
- 2001 NEUROLOGY
Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative
